PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Plant used in Chinese medicine fights chronic pain

2014-01-02
(Press-News.org) Contact information: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press
Plant used in Chinese medicine fights chronic pain A plant used for centuries as a pain reliever in Chinese medicine may be just what the doctor ordered, especially when it comes to chronic pain. A key pain-relieving ingredient is a compound known as dehydrocorybulbine (DHCB) found in the roots of the flowering plant Corydalis, a member of the poppy family, according to researchers who report their findings in the Cell Press journal Current Biology on January 2.

"Our study reports the discovery of a new natural product that can relieve pain," says Olivier Civelli of the University of California, Irvine. "This analgesic acts in animal assays against the three types of pain that afflict humans, including acute, inflammatory, and neuropathic or chronic pain."

Civelli, along with Xinmiao Liang, made the discovery as part of the "herbalome" project, an effort to catalogue all of the chemical components of traditional Chinese medicine. The Corydalis plants that were the focus of the new study grow mainly in central eastern China, where underground tubers are harvested, ground, and boiled in hot vinegar. Those concoctions are often prescribed to treat pain, including headaches and back pain.

The researchers went looking for compounds in Corydalis that appeared likely to act in a manner similar to morphine. "We landed on DHCB but rapidly found that it acts not through the morphine receptor but through other receptors, in particular one that binds dopamine," Civelli explains. The discovery adds to earlier evidence showing that the dopamine D2 receptor plays a role in pain sensation.

While Corydalis extracts or isolated DHCB work against all types of pain, they hold special promise for those who suffer with persistent, low-level chronic pain. For one thing, DHCB doesn't appear to lose effectiveness with time in the way that traditional opiate drugs do.

"We have good pain medications for acute pain: codeine or morphine, for example," Civelli says. "We have pain medication for inflammatory pain, such as aspirin or acetaminophen. We do not have good medications for chronic pain. DHCB may not be able to relieve strong chronic pain, but may be used for low-level chronic pain."

Although Corydalis preparations of various types can already be purchased online, Civelli and Liang say DHCB isn't ready for prime time just yet. Further testing for toxicity is needed before doctors should consider prescribing it to patients.

### Current Biology, Zhang et al.: "A novel analgesic Isolated from a Traditional Chinese Medicine."


ELSE PRESS RELEASES FROM THIS DATE:

JCI early table of contents for Jan. 2, 2014

2014-01-02
JCI early table of contents for Jan. 2, 2014 Opioid tolerance and pain hypersensitivity associated with mTOR activation Currently, opioids are the standard treatment for chronic pain. Patients on opioids for long periods of time become desensitized to ...

Opioid tolerance and pain hypersensitivity associated with mTOR activation

2014-01-02
Opioid tolerance and pain hypersensitivity associated with mTOR activation Currently, opioids are the standard treatment for chronic pain. Patients on opioids for long periods of time become desensitized to these drugs or become paradoxically hypersensitive ...

Doxorubicin-associated mitochondrial iron accumulation promotes cardiotoxicity

2014-01-02
Doxorubicin-associated mitochondrial iron accumulation promotes cardiotoxicity Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin ...

Biologists discover solution to problem limiting development of human stem cell therapies

2014-01-02
Biologists discover solution to problem limiting development of human stem cell therapies Biologists at UC San Diego have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic ...

Study on pregnancy and alcohol fails to take psychological factors into account

2014-01-02
Study on pregnancy and alcohol fails to take psychological factors into account "It is OK to drink a little bit of alcohol during pregnancy" or "a pregnant woman should not touch alcohol at all during her pregnancy". These statements represent the ...

Brain training works, but just for the practiced task, say Oregon researchers

2014-01-02
Brain training works, but just for the practiced task, say Oregon researchers Revealing pattern of changes detected in brain using MRI as 'trained' subjects show improved self-control EUGENE, Ore. -- Search for "brain training" on the Web. You'll find online exercises, ...

Mass spectrometer detection of 10 protein spots after acute high-altitude HBI

2014-01-02
Mass spectrometer detection of 10 protein spots after acute high-altitude HBI Hypobaric hypoxia can cause severe brain damage and mitochondrial dysfunction, and is involved in hypoxic brain injury. Dr. Jianyu Li and colleagues from Logistics College of Chinese ...

Differences in brain structure in patients with distinct sites of chronic pain

2014-01-02
Differences in brain structure in patients with distinct sites of chronic pain Accumulating evidence indicates that chronic pain of different etiologies is often associated with distinct gray matter volume reductions in multiple brain regions associated with ...

Diffusion tensor MRI-based tractography in evaluation of nerve root function

2014-01-02
Diffusion tensor MRI-based tractography in evaluation of nerve root function If bulging or protruding intervertebral discs occupies the intervertebral foramen, and nerve roots are compressed. The cross-sectional area of nerve root fibers is reduced, fiber bundles ...

Under pressure

2014-01-02
Under pressure A harness for guide dogs must suit both dog and owner Guide dogs lend their eyes to blind people, enabling them to find their way around in an environment they cannot see. Guide dogs require about four ...

LAST 30 PRESS RELEASES:

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

[Press-News.org] Plant used in Chinese medicine fights chronic pain